Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05735834
Title Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients (RITZ)
Acronym RITZ
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors International Extranodal Lymphoma Study Group (IELSG)
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA

Facility Status City State Zip Country Details
Aarhus University Hospital Aarhus Denmark Details
IRCCS Policlinico San Matteo Pavia Italy Details
Oslo University Hospital Oslo Norway Details
Karolinska University Hospital Stockholm Sweden Details
Oncology Institute of Southern Switzerland Bellinzona 6500 Switzerland Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field